跳至主要内容
临床试验/2023-503946-30-00
2023-503946-30-00招募中4 期

A randomized study to investigate central and cerebral hemodynamic effects and volume kinetics of Ringer´s Acetate compared with no intravenous fluids, during experimental hypovolemia compared with euvolemia, in healthy human volunteers.

Oslo University Hospital HF1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2023年6月26日最近更新:

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
12
试验地点
1
主要终点
Half-life of cardiac stroke volume relative to baseline

研究概览

简要总结

To assess the duration of hemodynamic effect of bolus Ringer`s acetate

入排标准

年龄范围
18 years 至 64 years(18-64 Years)
接受健康志愿者

入选标准

  • Participant must be 18 to 40 years of age inclusive, at the time of signing the informed consent
  • Participants who are overtly healthy as determined by medical evaluation including medical history, physical examination and focused cardiac ultrasound
  • Female participants: Use of adequate birth control for women of childbearing potential
  • Capable of giving signed informed consent as described in Appendix 1 which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol

排除标准

  • Any medical condition limiting physical exertional capacity or requiring regular medication (allergy and contraceptives excepted)
  • Breastfeeding
  • History of syncope (syncope of presumed vasovagal nature with known precipitating factor excepted)
  • Any known cardiac arrhythmia
  • Any drug (contraceptives excepted) used on a regular basis for a chronic condition (allergy excepted)

结局指标

主要结局

Half-life of cardiac stroke volume relative to baseline

Half-life of cardiac stroke volume relative to baseline

次要结局

  • Half-life of intravascular volume relative to baseline
  • Half-life of MCAv integral relative to baseline

研究者

发起方
Oslo University Hospital HF
申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Principal investigator

Scientific

Oslo University Hospital HF

研究点 (1)

Loading locations...

相似试验